A Randomized, Bouble-Blind, Multi-Cnter Phase III Study of Brivanib Plus Best Supportive Care (Bsc) Versus Placebo Plus Grant uri icon

date/time interval

  • May 11, 2010 - May 24, 2012

total award amount

  • 20651.25

direct costs

  • 16521.00

sponsor award ID

  • CA182-034-117

local award ID

  • 00077277